Prognostic biomarkers of cutaneous melanoma.

Ding, Liang; Gosh, Alexandra; Lee, Delphine J; Emri, Gabriella; Huss, Wendy J; Bogner, Paul N; Paragh, Gyorgy

Ding, Liang; Gosh, Alexandra; Lee, Delphine J; Emri, Gabriella; Huss, Wendy J; Bogner, Paul N; Paragh, Gyorgy.

Afiliación

Ding L; Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Gosh A; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Lee DJ; Department of Pathology, Buffalo General Medical Center, State University of New York, Buffalo, New York, USA.
Emri G; Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Huss WJ; Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Bogner PN; Division of Dermatology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA.
Paragh G; Division of Dermatology, Department of Medicine, The Lundquist Institute, Torrance, California, USA.

Photodermatol Photoimmunol Photomed ; 38(5): 418-434, 2022 Sep.

Article en En | MEDLINE | ID: mdl-34981569

Asunto(s)

Melanoma; Neoplasias Cutáneas; Biomarcadores de Tumor; Humanos; Melanoma/patología; Pronóstico; Neoplasias Cutáneas/patología; Melanoma Cutáneo Maligno

Palabras clave

biomarkers; mRNA signatures; melanoma; prognosis; tumor staging

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Photodermatol Photoimmunol Photomed Asunto de la revista: ALERGIA E IMUNOLOGIA / DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google